Skip to main content
. Author manuscript; available in PMC: 2016 Jan 8.
Published in final edited form as: Clin Infect Dis. 2015 Feb 19;60(11):1659–1666. doi: 10.1093/cid/civ116

Table 3.

Day of Notable Clinical Events for Fatal and Nonfatal Cases of Rocky Mountain Spotted Fever in 2 Tribal Communities in Eastern Arizona

Event All Cases Nonfatal Fatal P Value
Day of symptoms of first doctor visit Day 2 (1–11) Day 2 (1–11) Day 2 (1–7)
Day of symptoms that RMSF was first mentioned in medical record Day 3 (1–14) Day 3 (1–14) Day 7 (1–9) .005
Day of symptoms that doxycycline was started Day 3 (1–14) Day 3 (1–14) Day 7 (6–9) .000
Duration between first mention and treatment 0 days (0–10)  0 days (0–10)  0 days (0–5) 
Day of symptoms hospitalization occurred Day 5 (1–11) Day 4 (1–11) Day 5 (1–9)
Day of symptoms first CBC was obtained Day 3 (1–14) Day 3 (1–14) Day 5.5 (1–9)   .008
Day of symptoms sodium was first tested Day 3 (1–12) Day 3 (1–12) Day 5 (1–9) .017
Day of symptoms AST was first tested Day 3 (1–14) Day 3 (1–14) Day 7 (1–9) .006
Day of symptoms that death occurred NA     NA       Day 9 (6–20)

Data are presented as median (range).

Abbreviations: AST, aspartate aminotransferase; CBC, complete blood count; NA, not applicable; RMSF, Rocky Mountain spotted fever.